Dean Health System

Madison, Wisconsin 53717

0 studies enrolling now · 4 studies all time

What they study most

Advanced, Metastatic Breast Cancer, Chronic Myelogenous Leukemia - Chronic Phase, Diffuse Large B-cell Lymphoma, Multiple Sclerosis

Studies at this site

• Asciminib Monotherapy, With Dose Escalation, for 2nd and 1st Line Chronic Myelogenous Leukemia — Running, not enrolling
• Study of Efficacy and Safety of LEE011 in Postmenopausal Women With Advanced Breast Cancer — Completed
• Phase III Study of RAD001 Adjuvant Therapy in Poor Risk Patients With Diffuse Large B-Cell Lymphoma (DLBCL) of RAD001 Versus Matching Placebo After Patients Have Achieved Complete Response With First-line Rituximab-chemotherapy — Completed
• Determine Impact of Multiple NAb Tests on Treatment Compared to Usual Care of MS Patients on High-dose IFN Therapy — Completed